Morgan Stanley’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37B Buy
6,969,314
+29,951
+0.4% +$5.78M 0.08% 216
2025
Q4
$1.28B Buy
6,939,363
+216,469
+3% +$38M 0.08% 229
2025
Q3
$1.03B Buy
6,722,894
+614,559
+10% +$93M 0.06% 277
2025
Q2
$854M Sell
6,108,335
-1,775,933
-23% -$249M 0.06% 326
2025
Q1
$1.16B Sell
7,884,268
-766,277
-9% -$111M 0.08% 218
2024
Q4
$1.13B Buy
8,650,545
+2,238,089
+35% +$313M 0.08% 218
2024
Q3
$999M Buy
6,412,456
+212,300
+3% +$34.3M 0.07% 252
2024
Q2
$967M Sell
6,200,156
-1,350,418
-18% -$203M 0.07% 235
2024
Q1
$1.02B Sell
7,550,574
-4,979,586
-40% -$659M 0.08% 226
2023
Q4
$1.69B Buy
12,530,160
+5,899,307
+89% +$767M 0.07% 247
2023
Q3
$898M Sell
6,630,853
-122,028
-2% -$16.7M 0.09% 212
2023
Q2
$967M Buy
6,752,881
+276,857
+4% +$40.7M 0.1% 203
2023
Q1
$899M Buy
6,476,024
+1,364,725
+27% +$184M 0.1% 212
2022
Q4
$693M Buy
5,111,299
+780,597
+18% +$97.9M 0.08% 252
2022
Q3
$475M Buy
4,330,702
+136,897
+3% +$17.4M 0.06% 287
2022
Q2
$554M Buy
4,193,805
+2,642,478
+170% +$347M 0.07% 260
2022
Q1
$206M Sell
1,551,327
-39,790
-3% -$4.77M 0.03% 519
2021
Q4
$185M Sell
1,591,117
-621,459
-28% -$73.1M 0.02% 599
2021
Q3
$266M Buy
2,212,576
+51,021
+2% +$5.94M 0.04% 442
2021
Q2
$259M Buy
2,161,555
+1,034,240
+92% +$113M 0.03% 451
2021
Q1
$112M Sell
1,127,315
-123,105
-10% -$12.4M 0.02% 706
2020
Q4
$125M Sell
1,250,420
-813,728
-39% -$86.2M 0.02% 622
2020
Q3
$226M Buy
2,064,148
+188,890
+10% +$21M 0.04% 350
2020
Q2
$198M Buy
1,875,258
+760,808
+68% +$78.6M 0.04% 355
2020
Q1
$99.5M Sell
1,114,450
-3,663
-0.3% -$345K 0.03% 490
2019
Q4
$111M Buy
1,118,113
+2,976
+0.3% +$280K 0.03% 564
2019
Q3
$99.4M Sell
1,115,137
-100,809
-8% -$8.74M 0.03% 562
2019
Q2
$100M Sell
1,215,946
-2,500,998
-67% -$196M 0.03% 554
2019
Q1
$301M Buy
3,716,944
+2,602,110
+233% +$205M 0.09% 249
2018
Q4
$84.7M Sell
1,114,834
-114,895
-9% -$8.97M 0.03% 583
2018
Q3
$97.3M Buy
1,229,729
+63,608
+5% +$4.81M 0.02% 609
2018
Q2
$81.9M Sell
1,166,121
-61,028
-5% -$4.39M 0.02% 669
2018
Q1
$85.8M Buy
1,227,149
+7,894
+0.6% +$547K 0.02% 654
2017
Q4
$84.6M Buy
1,219,255
+66,051
+6% +$4.45M 0.02% 666
2017
Q3
$78.1M Sell
1,153,204
-97,885
-8% -$6.18M 0.02% 681
2017
Q2
$85.3M Buy
1,251,089
+42,600
+4% +$2.78M 0.03% 630
2017
Q1
$75.3M Buy
1,208,489
+84,139
+7% +$4.9M 0.02% 700
2016
Q4
$61.4M Sell
1,124,350
-93,990
-8% -$5.34M 0.02% 762
2016
Q3
$80.1M Buy
1,218,340
+160,841
+15% +$10.5M 0.03% 618
2016
Q2
$63.9M Buy
1,057,499
+64,869
+7% +$3.77M 0.02% 678
2016
Q1
$55.9M Buy
992,630
+206,436
+26% +$12.4M 0.02% 700
2015
Q4
$53.4M Buy
786,194
+110,393
+16% +$7.24M 0.02% 749
2015
Q3
$43M Buy
675,801
+22,021
+3% +$1.45M 0.02% 880
2015
Q2
$41.7M Sell
653,780
-42,913
-6% -$2.94M 0.01% 974
2015
Q1
$47.7M Sell
696,693
-197,514
-22% -$13.7M 0.02% 883
2014
Q4
$62.9M Sell
894,207
-946,806
-51% -$67.8M 0.02% 727
2014
Q3
$132M Sell
1,841,013
-518,841
-22% -$38M 0.05% 406
2014
Q2
$175M Buy
2,359,854
+1,485,001
+170% +$107M 0.07% 311
2014
Q1
$56.8M Sell
874,853
-266,188
-23% -$17.2M 0.02% 693
2013
Q4
$67.7M Buy
1,141,041
+150,943
+15% +$8.2M 0.03% 604
2013
Q3
$51.4M Buy
990,098
+64,908
+7% +$3.26M 0.02% 666
2013
Q2
$43.8M Buy
+925,190
New +$47.1M 0.02% 708

Other funds holding AZN